Figure S2 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways

Figure S2 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways

<p>Figure S2. Lurbinectedin sensitivity (IC50) correlation with MYC expression and changes in expression of NE markers.</p>

Na minha lista:
Detalhes bibliográficos
Autor principal: Subhamoy Chakraborty (16648124) (author)
Outros Autores: Charles Coleman (16648127) (author), Parvathy Manoj (16648130) (author), Deniz Demircioglu (15306139) (author), Nisargbhai Shah (16648133) (author), Elisa de Stanchina (14954757) (author), Charles M. Rudin (11572933) (author), Dan Hasson (15306151) (author), Triparna Sen (14126577) (author)
Publicado em: 2025
Assuntos:
Cancer
Cancer Detection and Diagnosis
Methods and Technology
Biomarkers
Lung Cancer
Preclinical Models
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados

Registros relacionados